Stay updated on AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial
Sign up to get notified when there's something new on the AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial page.

Latest updates to the AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays the ClinicalTrials.gov record for the completed SYMPHONY Phase 3 study of AXS-12 in narcolepsy, including its eligibility criteria, locations, outcomes, and study history, instead of a 403 error screen.SummaryDifference62%

- Check8 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedA site-wide NIH notice appears above the blocked study record, linking to transition updates and explaining that NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check22 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2, while the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer revision number changed from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now renders a 403 Forbidden error with a minimal HTML structure and a Home link, indicating access to the study record is blocked. This change replaces the previous detailed study content and navigation shown on the page.SummaryDifference17%

Stay in the know with updates to AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial page.